A

ADMA

ADMA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
20%Bearish
Buy/Sell Ratio3% buys
BearishBullish
ADMA Live QuoteReal-time
$13.56
+$2.33(+20.75%)1M
Day Range$13.50 – $14.20
Open$13.63
Previous Close$13.63
Volume3.18M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.01B
P/E Ratio (TTM)17.6
Forward P/E13.9
EPS (TTM)$0.77
Price to Book6.9
Dividend Yield0.65%
Beta (Volatility)0.66
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $13.56 (48%)
Low: $7.21High: $20.46
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$18.00-88.0% upside

Insider Buys

4

$468K

Insider Sales

20

$17.44M

Total Volume

$17.91M

24 transactions

Net Activity

$16.97M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 97% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
E
1

Elms Steve

Dir

1 buys1 sells

$9.05M total

G
2

Grossman Adam S

Pres, CEO

0 buys14 sells

$7.32M total

G
3

Guiheen Lawrence P.

Dir

0 buys2 sells

$602K total

G
4

Grossman Jerrold B

Dir

3 buys1 sells

$464K total

T
5

Tade Brad L.

CFO, Treasurer

0 buys1 sells

$317K total

Trading History
ADMA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 5, 2026

2 weeks ago

Grossman Adam S

Pres, CEO

CEO
Sell147.0K$12.00$1.76M

May 27, 2026

5 months ago

Grossman Jerrold B

Dir

Director
Buy6.4K$7.91$51K

May 12, 2026

6 months ago

Grossman Jerrold B

Dir

Director
Buy12.5K$8.01$100K

May 11, 2026

6 months ago

Grossman Jerrold B

Dir

Director
Buy12.5K$8.01$100K

Mar 16, 2026

8 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$15.16$318K

Mar 9, 2026

8 months ago

Kestenberg-Messina Kaitlin M.

COO, SVP, Compliance

COO
Sell10.1K$15.63$158K

Mar 5, 2026

8 months ago

Elms Steve

Dir

Director
Buy14.0K$15.53$217K

Feb 17, 2026

9 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$16.08$338K

Dec 15, 2025

11 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$19.79$416K

Nov 19, 2025

12 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$16.00$336K

Oct 24, 2025

13 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$16.00$336K

Sep 15, 2025

14 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$16.13$339K

Aug 15, 2025

15 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$16.88$354K

Jul 15, 2025

16 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$18.66$392K

Jun 16, 2025

17 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$20.81$437K

Jun 12, 2025

17 months ago

Elms Steve

Dir

Director
Sell425.6K$20.74$8.83M

Jun 9, 2025

17 months ago

Guiheen Lawrence P.

Dir

Director
Sell20.0K$20.96$419K

Jun 9, 2025

17 months ago

Grossman Jerrold B

Dir

Director
Sell10.0K$21.31$213K

May 21, 2025

18 months ago

Guiheen Lawrence P.

Dir

Director
Sell9.0K$20.29$183K

May 15, 2025

18 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$19.45$408K

Apr 15, 2025

19 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$21.46$451K

Mar 19, 2025

20 months ago

Grossman Adam S

Pres, CEO

CEO
Sell21.0K$18.92$397K

Nov 22, 2024

24 months ago

Tade Brad L.

CFO, Treasurer

CFO
Sell15.0K$21.15$317K

Nov 22, 2024

24 months ago

Grossman Adam S

Pres, CEO

CEO
Sell49.0K$21.10$1.03M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ADMA Buy Conviction3%
Industry Rank#305 of 570
Volume Contribution0.1%
Total Industry Activity$15.24B

ADMA has an insider buy conviction of 3%, compared to the Unknown sector buy average of 6%. ADMA ranks #305 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ADMA

Over the last 90 days, corporate insiders at ADMA (ADMA) engaged in a total of 24 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 20 were sales. The total volume of insider trading reached $17.91M.

The net insider activity for ADMA shows a net selling bias of $16.97M. This activity represents a 3% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Elms Steve (Dir), who traded 425.6K shares valued at $8.83M on Jun 12, 2025.

Live Market News & Developments
Aggregated real-time headlines for ADMA (ADMA)
6 updates

ADMA Biologics Inc (ADMA) Stock Forecasts

Yahoo Finance9h ago

ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?

Yahoo Finance7d ago

Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

Yahoo Finance68d ago

ADMA Biologics (ADMA) Stock Looks Undervalued Even After A 5 Year Run

Yahoo Finance126d ago

Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

Yahoo Finance142d ago

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

Yahoo Finance110d ago

FAQs About ADMA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ADMA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ADMA is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 4 purchases and 20 sales by company executives over the last 90 days.

The CEO Conviction Index for ADMA is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.